CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $1.05M invested in Can-Fite BioPharma in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$239K
2
+$91K
3
+$18K

Top Sellers

1
-$114K
2
-$99.1K
3
-$48.9K
4
XT
XTX Topco
Cayman Islands
-$28K
5
Jane Street
Jane Street
New York
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$421K
2
$359K
3
$91K
4
$88K
5
$27K
6
$23K
7
$18K
8
$13K
9
$3K
10
$2.51K
11
$1.22K
12
–
13
–
14
–